NEK2 anticorps
-
- Antigène Voir toutes NEK2 Anticorps
- NEK2 (NIMA (Never in Mitosis Gene A)-Related Kinase 2 (NEK2))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NEK2 est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF), Immunochromatography (IC)
- Fonction
- Rabbit polyclonal antibody to NEK2
- Specificité
- Recognizes endogenous levels of NEK2 protein.
- Attributs du produit
- Rabbit polyclonal antibody to NEK2
- Purification
- The antibody was purified by immunogen affinity chromatography.
- Immunogène
- Recombinant full length protein of human NEK2
- Top Product
- Discover our top product NEK2 Anticorps primaire
-
-
- Indications d'application
- WB (1:500 - 1:2000), IF/IC (1:50 - 1:200)
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- NEK2 (NIMA (Never in Mitosis Gene A)-Related Kinase 2 (NEK2))
- Autre désignation
- NEK2 (NEK2 Produits)
- Synonymes
- anticorps AA617254, anticorps C77054, anticorps HsPK21, anticorps NEK2A, anticorps NLK1, anticorps ATNEK2, anticorps NIMA-RELATED KINASE2, anticorps NIMA-related kinase 2, anticorps T9J14.24, anticorps T9J14_24, anticorps NIMA related kinase 2, anticorps NIMA (never in mitosis gene a)-related expressed kinase 2, anticorps NIMA-related kinase 2, anticorps NEK2, anticorps Nek2
- Sujet
- NEK2A, NLK1, Serine/threonine-protein kinase Nek2, HSPK 21, Never in mitosis A-related kinase 2, NimA-related protein kinase 2, NimA-like protein kinase 1
- ID gène
- 4751, 18005
- UniProt
- P51955, O35942
- Pathways
- M Phase
-